Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Ayahuasca

Ritualistic ayahuasca users tend to have positive health and psychosocial well-being

by Eric W. Dolan
March 2, 2019
in Ayahuasca, Psychopharmacology
(Photo credit: BurningMax)

(Photo credit: BurningMax)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

New research provides evidence that the ritualistic use of the psychedelic drug ayahuasca is not a significant public health concern — and could in fact have potential benefits. The study has been published in the Journal of Psychoactive Drugs.

“Ayahuasca is a decoction originally from the Amazon rainforest that has been spread throughout the world. At ICEERS, we are interested in researching the eventual risks and benefits of its use,” said study author Jose Carlos Bouso, the scientific director of the International Center for Ethnobotanical Education, Research, and Services in Spain.

“We studied in the past its neuropsychiatric effects on long-term ayahuasca users and did not find any disturbances. Now we are interested in studying the effects of ayahuasca from a public health perspective.”

The researchers surveyed 380 ritualistic ayahuasca users in Spain regarding their self-perceived health, body mass index, presence of chronic disease, sleep quality, and several other factors. Most of the participants had taken ayahuasca between one and 10 times in their lifetime. But a substantial percentage of participants (29.7%) reported taking ayahuasca more than 100 times.

The majority of the sample (96.6%) described their health as “good,” “very good,” or “excellent.” In addition, 43.7% reported being “quite happy,” 39.2% reported being “very happy,” and 7.5% reported being “immensely happy.”

Only 7.4% of participants had high cholesterol or blood pressure level, and 47% had visited a doctor between one and three times in the previous six months. Only 19% had visited a psychologist or psychiatrist in the previous six months.

The prevalence of chronic diseases was also lower among ritualistic ayahuasca users compared to the general Spanish population, while the prevalence of mental disturbance was similar between ayahuasca users and the general population.

“The key finding can be summarized using the following sentence of the Abstract section: ‘a respectful and controlled use of ayahuasca taken in community settings can be incorporated into modern society with benefits to public health.’ With the health indicators used, we noted that regular ayahuasca users have good general health, display healthy lifestyles and coping strategies, or show appropriate levels of social support and participation in cultural activities,” Bouso told PsyPost.

“This could serve as an example of how a traditional practice, even with its exoticism and cultural differences, can be effectively integrated in our society if it is used in controlled and respectful contexts.”

The study — like all research — includes some limitations. The use of a cross-sectional survey, for example, makes it difficult to assess the direction of cause and effect. It is possible that people with healthier lifestyles are drawn to ayahuasca, rather than ayahuasca use contributing to healthier lifestyles.

“The main limitation of this study is that the sample was self-selected. It is possible that only those who obtain some benefit from the regular use of ayahuasca are able to maintain this practice, so we may be underestimating potential risks and overestimating potential benefits. Further studies with larger samples are warranted,” Bouso said.

“This article will be part of a special 50th anniversary issue of the Journal of Psychoactive Drugs. MAPS (Multidisciplinary Association for Psychedelic Studies), the organization that is coordinating the issue, stated: ‘This carefully conducted study adds to the growing body of evidence that used carefully in specific settings, ayahuasca and other psychedelics may have real benefits for mental health and well-being. MAPS is delighted to be able to include these encouraging results in the Journal of Psychoactive Drugs’ historic 50th anniversary theme issue highlighting the leading edge of psychedelic research.’ The complete special issue will be available in print by June 2019.”

“ICEERS is also organizing the World Ayahuasca Conference, the biggest gathering in the world about ayahuasca. We invite readers to see the web site of the conference: http://www.ayaconference.com.”

The study, “Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users“, was authored by Genís Ona, Maja Kohek, Tomàs Massaguer, Alfred Gomariz, Daniel F. Jiménez, Rafael G. Dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar- Córcoles, and José Carlos Bouso.

TweetSendScanShareSendPin4ShareShareShareShareShare

RELATED

Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Stimulant medication improves working memory of children with ADHD, study finds
ADHD

New study exposes gap between ADHD drug use and safety research in children

June 30, 2025

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled safety data for these medications in children exists for only one year, highlighting a gap in long-term evidence.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails
Can Acacia catechu and Scutellaria baicalensis extracts enhance brain function?
Dementia

Ashwagandha extract boosts memory and cognition in people with mild cognitive impairment, study finds

June 27, 2025

Researchers found that a standardized extract of ashwagandha improved memory, attention, and spatial reasoning in adults with mild cognitive impairment, outperforming a placebo in a two-month clinical trial with no reported side effects.

Read moreDetails
Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Scientists are uncovering more and more unsettling facts about our politics

People with depression face significantly greater social and health-related challenges

Stress disrupts gut and brain barriers by reducing key microbial metabolites, study finds

New research reveals hidden biases in AI’s moral advice

7 subtle signs you are being love bombed—and how to slow things down before you get hurt

A simple breathing exercise enhances emotional control, new research suggests

Despite political tensions, belief in an impending U.S. civil war remains low

Girls are better than boys at detecting their own ADHD symptoms

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy